A Phase I/II, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activities of CS2009, a Tri-specific Antibody Targeting PD-1/VEGFA/CTLA-4, as Monotherapy and Combination Therapy in Participants With Advanced Solid Tumors
CStone Pharmaceuticals
Summary
This is a first-in-human (FIH), open-label, and multi-center Phase I/II study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of CS2009 as Monotherapy and Combination Therapy in Participants with Advanced Solid Tumors. The study is comprised of a Phase I dose escalation and Phase II dose expansion.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Evidence of a personally signed and dated informed consent document. * Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures. * Age ≥ 18 years on the day of signing informed consent. Phase I: * Pathologically or cytologically confirmed, unresectable advanced solid tumors, including but not limited to non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), gastric cancer (GC), ovarian cancer (OC), cervical cancer (CC), etc. * Failure of establi…
Interventions
- DrugCS2009
CS2009 will be administered via intravenous (IV) infusion on Day 1 of repeated 21-day cycles (Q3W).
- DrugCS2009
CS2009 will be administered via intravenous (IV) infusion on Day 1 of repeated 14/21-day cycles (Q2W/Q3W).
- DrugPemetrexed
IV infusion
- DrugCarboplatin
IV infusion
- DrugPaclitaxel
IV infusion
- DrugEtoposide
IV infusion
- DrugNab-paclitaxel
IV infusion
- DrugOxaliplatin
IV infusion
- DrugCapecitabine
oral tablets
- DrugDocetaxel
IV infusion
- DrugLeucovorin
IV infusion
- Drug5-FU
IV infusion
- DrugCisplatin
IV infusion
- DrugGemcitabine
IV infusion
- DrugIrinotecan
IV infusion
Locations (33)
- START Los Angeles, LLCLos Angeles, California
- NEXT DallasIrving, Texas
- Alfred Hospital (Alfred Health)Melbourne
- Austin Hospital (Austin Health)Melbourne
- Monash Medical Centre (Monash Health)Melbourne
- Peter Maccallum Cancer Centre ResearchMelbourne